These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16504625)

  • 1. Clinical trial issues in weight-loss therapy.
    Patel MR; Donahue M; Wilson PW; Califf RM
    Am Heart J; 2006 Mar; 151(3):633-42. PubMed ID: 16504625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals.
    Hemo B; Endevelt R; Porath A; Stampfer MJ; Shai I
    Diabetes Res Clin Pract; 2011 Nov; 94(2):269-75. PubMed ID: 21907442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining behavioral and pharmacological treatments for obesity.
    Phelan S; Wadden TA
    Obes Res; 2002 Jun; 10(6):560-74. PubMed ID: 12055334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What effect does losing weight have on hypertension?].
    Engeli S
    MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
    Downey M; Still C; Sharma AM
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):321-7. PubMed ID: 21878755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity.
    Fabricatore AN; Wadden TA
    Annu Rev Clin Psychol; 2006; 2():357-77. PubMed ID: 17716074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    Fujioka K
    Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
    Douketis JD; Sharma AM
    Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical therapy for the patient with obesity.
    Bray GA; Ryan DH
    Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008.
    Samaranayake NR; Ong KL; Leung RY; Cheung BM
    Ann Epidemiol; 2012 May; 22(5):349-53. PubMed ID: 22305325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic options for overweight adolescents.
    Dunican KC; Desilets AR; Montalbano JK
    Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.